The global interventional cardiology devices market size is expected to reach USD 22.35 billion by 2030. The market is expected to expand at a CAGR of 7.2% from 2023 to 2030 Demand for interventional cardiology devices is on the rise owing to favorable reimbursement policies for coronary intervention procedures, rising prevalence of cardiovascular diseases (CVDs) and diabetes across the globe, and the launch of new product lines in the market. Cardiovascular diseases have become one of the major causes of mortality and morbidity in the world. Coronary artery disease and congenital heart defects are the major cardiovascular diseases that are prevalent across the globe.
Furthermore, the adoption of unhealthy lifestyles, such as smoking, a sedentary lifestyle, and improper diet, is responsible for diabetes. Cardiac catheterization, angioplasty, and Percutaneous Coronary Intervention (PCI) are some of the major procedures used for the treatment of cardiovascular diseases. Since diabetes is one of the major reasons behind triggering cardiovascular diseases, increasing diabetes cases are expected to surge the demand for interventional cardiology devices over the forecast period. Although the market is anticipated to expand over the coming years, it might witness slower growth possibly brought on by the high price of medical devices, especially in developing economies with insufficient insurance coverage.
•Technological advancements in coronary stents, such as the development of bifurcated stents and the use of biodegradable materials, have led to efficient and improved outcomes of CVD treatment. Companies are proactively involved in product developments and partnerships and strategic collaborations. The aforementioned factors are expected to propel industry growth over the forecast period
•Asia Pacific region is expected to advance at the fastest CAGR of 7.9% over the forecast period. This growth can be attributed to several factors, including the increasing incidence of coronary artery disease (CAD) and improved screening measures for this disorder.
•The market is fragmented due to the presence of several players. This is expected to intensify the competition in the coming years. Market players are adopting various strategic initiatives such as partnerships, sales & marketing activities, mergers & acquisitions, service expansion, integrated offerings, and product launches to increase their market presence
Furthermore, the adoption of unhealthy lifestyles, such as smoking, a sedentary lifestyle, and improper diet, is responsible for diabetes. Cardiac catheterization, angioplasty, and Percutaneous Coronary Intervention (PCI) are some of the major procedures used for the treatment of cardiovascular diseases. Since diabetes is one of the major reasons behind triggering cardiovascular diseases, increasing diabetes cases are expected to surge the demand for interventional cardiology devices over the forecast period. Although the market is anticipated to expand over the coming years, it might witness slower growth possibly brought on by the high price of medical devices, especially in developing economies with insufficient insurance coverage.
Interventional Cardiology Devices Market Report Highlights
•The coronary stents segment dominated the market with the largest revenue share of 64.6% in 2022. DES makes up the majority of sales in the coronary stent category.•Technological advancements in coronary stents, such as the development of bifurcated stents and the use of biodegradable materials, have led to efficient and improved outcomes of CVD treatment. Companies are proactively involved in product developments and partnerships and strategic collaborations. The aforementioned factors are expected to propel industry growth over the forecast period
•Asia Pacific region is expected to advance at the fastest CAGR of 7.9% over the forecast period. This growth can be attributed to several factors, including the increasing incidence of coronary artery disease (CAD) and improved screening measures for this disorder.
•The market is fragmented due to the presence of several players. This is expected to intensify the competition in the coming years. Market players are adopting various strategic initiatives such as partnerships, sales & marketing activities, mergers & acquisitions, service expansion, integrated offerings, and product launches to increase their market presence
Table of Contents
Chapter 1. Methodology and Scope1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. 1.8. 1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Interventional Cardiology Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Interventional Cardiology Devices Market Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Interventional Cardiology Devices Market: Product Estimates & Trend Analysis
4.1. Interventional Cardiology Devices Market: Key Takeaways
4.2. Interventional Cardiology Devices Market: Product Movement & Market Share Analysis, 2022 & 2030
4.3. Coronary Stents
4.3.1. Coronary stents market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2. DES
4.3.2.1. DES market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.3. BMS
4.3.3.1. BMS market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.4. BRS
4.3.4.1. BRS market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. PTCA Balloon Catheters
4.4.1. PTCA balloon catheters market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Normal
4.4.2.1. Normal market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Specialty
4.4.3.1. Specialty market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.4. DCB
4.4.4.1. DCB market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Accessory Devices
4.5.1. Accessory devices market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2. PTCA guidewires
4.5.2.1. PTCA guidewires market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3. Diagnostic catheters
4.5.3.1. Diagnostic catheters market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.4. PTCA guiding catheters
4.5.4.1. PTCA guiding catheters market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.5. Introducer sheaths
4.5.5.1. Introducer sheaths market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Intravascular imaging catheters and pressure guidewires
4.6.1. Intravascular imaging catheters and pressure guidewires market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Interventional Cardiology Devices Market: Regional Estimates & Trend Analysis
5.1. Regional Outlook
5.2. Interventional Cardiology Devices Market by Region: Key Takeaways
5.3. North America
5.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.3.2. U.S.
5.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.3.3. Canada
5.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4. Europe
5.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.2. UK
5.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.3. Germany
5.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.4. France
5.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.5. Italy
5.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.6. Spain
5.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.7. Sweden
5.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.8. Norway
5.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.9. Denmark
5.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5. Asia Pacific
5.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.2. Japan
5.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.3. China
5.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.4. India
5.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.5. Australia
5.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.6. Thailand
5.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.7. South Korea
5.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6. Latin America
5.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.2. Brazil
5.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.3. Mexico
5.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.4. Argentina
5.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7. MEA
5.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.2. Saudi Arabia
5.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.3. South Africa
5.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.4. UAE
5.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.5. Kuwait
5.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Market Participant Categorization
6.2.1. Abbott Laboratories
6.2.1.1. Company overview
6.2.1.2. Financial performance
6.2.1.3. Product benchmarking
6.2.1.4. Strategic initiatives
6.2.2. Medtronic
6.2.2.1. Company overview
6.2.2.2. Financial performance
6.2.2.3. Product benchmarking
6.2.2.4. Strategic initiatives
6.2.3. Boston Scientific
6.2.3.1. Company overview
6.2.3.2. Financial performance
6.2.3.3. Product benchmarking
6.2.3.4. Strategic initiatives
6.2.4. Spectranetics
6.2.4.1. Company overview
6.2.4.2. Financial performance
6.2.4.3. Product benchmarking
6.2.4.4. Strategic initiatives
6.2.5. Cardinal Health
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
6.2.6. Philips Healthcare
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product benchmarking
6.2.6.4. Strategic initiatives
6.2.7. Terumo
6.2.7.1. Company overview
6.2.7.2. Financial performance
6.2.7.3. Product benchmarking
6.2.7.4. Strategic initiatives
6.2.8. Alvimedica
6.2.8.1. Company overview
6.2.8.2. Financial performance
6.2.8.3. Product benchmarking
6.2.8.4. Strategic initiatives
6.2.9. Teleflex Medical
6.2.9.1. Company overview
6.2.9.2. Financial performance
6.2.9.3. Product benchmarking
6.2.9.4. Strategic initiatives
6.2.10. B. Braun
6.2.10.1. Company overview
6.2.10.2. Financial performance
6.2.10.3. Product benchmarking
6.2.10.4. Strategic initiatives
6.2.11. Biosensors International
6.2.11.1. Company overview
6.2.11.2. Financial performance
6.2.11.3. Product benchmarking
6.2.11.4. Strategic initiatives
6.2.12. Meril Life Sciences
6.2.12.1. Company overview
6.2.12.2. Financial performance
6.2.12.3. Product benchmarking
6.2.12.4. Strategic initiatives
6.2.13. BIOTRONIK
6.2.13.1. Company overview
6.2.13.2. Financial performance
6.2.13.3. Product benchmarking
6.2.13.4. Strategic initiatives
6.2.14. ACIST Medical Systems
6.2.14.1. Company overview
6.2.14.2. Financial performance
6.2.14.3. Product benchmarking
6.2.14.4. Strategic initiatives
6.2.15. ASAHI INTECC
6.2.15.1. Company overview
6.2.15.2. Financial performance
6.2.15.3. Product benchmarking
6.2.15.4. Strategic initiatives
6.2.16. CID Vascular
6.2.16.1. Company overview
6.2.16.2. Financial performance
6.2.16.3. Product benchmarking
6.2.16.4. Strategic initiatives
6.2.17. Cook Medical
6.2.17.1. Company overview
6.2.17.2. Financial performance
6.2.17.3. Product benchmarking
6.2.17.4. Strategic initiatives
6.2.18. Medinol
6.2.18.1. Company overview
6.2.18.2. Financial performance
6.2.18.3. Product benchmarking
6.2.18.4. Strategic initiatives
6.2.19. Merit Medical Systems
6.2.19.1. Company overview
6.2.19.2. Financial performance
6.2.19.3. Product benchmarking
6.2.19.4. Strategic initiatives
6.2.20. NuMED
6.2.20.1. Company overview
6.2.20.2. Financial performance
6.2.20.3. Product benchmarking
6.2.20.4. Strategic initiatives
6.2.21. OpSens
6.2.21.1. Company overview
6.2.21.2. Financial performance
6.2.21.3. Product benchmarking
6.2.21.4. Strategic initiatives
6.2.22. Vascular Solutions
6.2.22.1. Company overview
6.2.22.2. Financial performance
6.2.22.3. Product benchmarking
6.2.22.4. Strategic initiatives
6.2.23. Zeon Medical
6.2.23.1. Company overview
6.2.23.2. Financial performance
6.2.23.3. Product benchmarking
6.2.23.4. Strategic initiatives
Table 1 Table 2 North America interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 3 North America interventional cardiology devices market, by region, 2018-2030 (USD Million)
Table 4 U.S. interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 5 Canada interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 6 Europe interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 7 Europe interventional cardiology devices market, by region, 2018-2030 (USD Million)
Table 8 Germany interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 9 UK interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 10 France interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 11 Italy interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 12 Spain interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 13 Sweden interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 14 Norway interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 15 Denmark interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 16 Asia Pacific interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 17 Asia Pacific interventional cardiology devices market, by region, 2018-2030 (USD Million)
Table 18 China interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 19 Japan interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 20 India interventional cardiology devices market, by product, 2018-2030, (USD Million)
Table 21 Australia interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 22 Thailand interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 23 South Korea interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 24 Latin America interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 25 Latin America interventional cardiology devices market, by region, 2018-2030 (USD Million)
Table 26 Brazil interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 27 Mexico interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 28 Argentina interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 29 Middle East and Africa interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 30 Middle East and Africa interventional cardiology devices market, by region, 2018-2030 (USD Million)
Table 31 South Africa interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 32 Saudi Arabia interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 33 UAE interventional cardiology devices market, by product, 2018-2030 (USD Million)
Table 34 Kuwait interventional cardiology devices market, by product, 2018-2030 (USD Million)
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Interventional cardiology devices: Market outlook
Fig. 9 Interventional cardiology devices: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Interventional cardiology devices market driver impact
Fig. 15 Interventional cardiology devices market restraint impact
Fig. 16 Interventional cardiology devices market strategic initiatives analysis
Fig. 17 Interventional cardiology devices market: Product movement analysis
Fig. 18 Interventional cardiology devices market: Product outlook and key takeaways
Fig. 19 Coronary stents market estimates and forecasts, 2018-2030, (USD million)
Fig. 20 DES market estimates and forecasts, 2018-2030 (USD Million)
Fig. 21 BMS market estimates and forecasts, 2018-2030 (USD Million)
Fig. 22 BRS market estimates and forecasts, 2018-2030 (USD Million)
Fig. 23 PTCA balloon catheters market estimates and forecasts, (USD million) 2018-2030
Fig. 24 Normal market estimates and forecasts, 2018-2030 (USD Million)
Fig. 25 Specialty market estimates and forecasts, 2018-2030 (USD Million)
Fig. 26 DCB market estimates and forecasts, 2018-2030 (USD Million)
Fig. 27 Accessory devices market estimates and forecasts, 2018-2030, (USD million)
Fig. 28 PTCA guidewires market estimates and forecasts, 2018-2030, (USD million)
Fig. 29 Diagnostic catheters market estimates and forecasts, 2018-2030 (USD Million)
Fig. 30 PTCA guiding catheters market estimates and forecasts, 2018-2030 (USD Million)
Fig. 31 Introducer sheaths market estimates and forecasts, 2018-2030 (USD Million)
Fig. 32 Intravascular imaging catheters and pressure guidewire market estimates and forecasts, 2018-2030 (USD Million)
Fig. 33 Global interventional cardiology devices market: Regional movement analysis
Fig. 34 Global interventional cardiology devices market: Regional outlook and key takeaways
Fig. 35 North America market estimates and forecasts, 2018-2030 (USD Million)
Fig. 36 U.S. market estimates and forecasts, 2018-2030 (USD Million)
Fig. 37 Canada market estimates and forecasts, 2018-2030 (USD Million)
Fig. 38 Europe market estimates and forecasts, 2018-2030 (USD Million)
Fig. 39 UK market estimates and forecasts, 2018-2030 (USD Million)
Fig. 40 Germany market estimates and forecasts, 2018-2030 (USD Million)
Fig. 41 France market estimates and forecasts, 2018-2030 (USD Million)
Fig. 42 Italy market estimates and forecasts, 2018-2030 (USD Million)
Fig. 43 Spain market estimates and forecasts, 2018-2030 (USD Million)
Fig. 44 Sweden market estimates and forecasts, 2018-2030 (USD Million)
Fig. 45 Norway market estimates and forecasts, 2018-2030 (USD Million)
Fig. 46 Denmark market estimates and forecasts, 2018-2030 (USD Million)
Fig. 47 Asia Pacific market estimates and forecasts, 2018-2030 (USD Million)
Fig. 48 Japan market estimates and forecasts, 2018-2030 (USD Million)
Fig. 49 China market estimates and forecasts, 2018-2030 (USD Million)
Fig. 50 India market estimates and forecasts, 2018-2030 (USD Million)
Fig. 51 Australia market estimates and forecasts, 2018-2030 (USD Million)
Fig. 52 Thailand market estimates and forecasts, 2018-2030 (USD Million)
Fig. 53 South Korea market estimates and forecasts, 2018-2030 (USD Million)
Fig. 54 Latin America market estimates and forecasts, 2018-2030 (USD Million)
Fig. 55 Brazil market estimates and forecasts, 2018-2030 (USD Million)
Fig. 56 Mexico market estimates and forecasts, 2018-2030 (USD Million)
Fig. 57 Argentina market estimates and forecasts, 2018-2030 (USD Million)
Fig. 58 Middle East and Africa market estimates and forecasts, 2018-2030 (USD Million)
Fig. 59 Saudi Arabia market estimates and forecasts, 2018-2030 (USD Million)
Fig. 60 South Africa market estimates and forecasts, 2018-2030 (USD Million)
Fig. 61 UAE market estimates and forecasts, 2018 -2030, (USD million)
Fig. 62 Kuwait market estimates and forecasts, 2018-2030 (USD Million)
Companies Mentioned
- Abbott Laboratories
- Medtronic
- Boston Scientific
- Spectranetics
- Cardinal Health
- Philips Healthcare
- Terumo
- Alvimedica
- Teleflex Medical
- B. Braun
- Biosensors International
- Meril Life Sciences
- BIOTRONIK
- ACIST Medical Systems
- ASAHI INTECC
- CID Vascular
- Cook Medical
- Medinol
- Merit Medical Systems
- NuMED
- OpSens
- Vascular Solutions
- Zeon Medical
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | October 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 12.91 Billion |
| Forecasted Market Value ( USD | $ 22.35 Billion |
| Compound Annual Growth Rate | 7.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
